on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Announces Investor Webcast on August 14, 2025
Jaguar Health, Inc. is set to conduct an investor webcast on August 14, 2025, at 8:30 a.m. Eastern, following the filing of its second-quarter financial results on Form 10-Q for the period ended June 30, 2025. The webcast aims to provide corporate updates and a thorough review of the financials.
The company's CEO, Lisa Conte, is scheduled to present on August 20, 2025, at the Emerging Growth Conference, focusing on near-term catalysts for growth. This presentation will be available through online registration, with a replay accessible on EmergingGrowth.com.
Jaguar Health, a pharmaceutical company, develops plant-based medications for gastrointestinal ailments. Their portfolio includes the FDA-approved Mytesi®, addressing noninfectious diarrhea in HIV/AIDS patients under antiretroviral therapy.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news